A Phase 4 interventional study of oral azithromycin and no azithromycin in Maternal and Neonatal Sepsis and Intrapartum Antibiotics, sponsored by Armed Forces Hospital, Pakistan. Not yet recruiting. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-05-06.
Sponsored by Armed Forces Hospital, Pakistan · Phase 4, Interventional, and Treatment
In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother
183 studies on the registry are indexed under Neonatal Sepsis; 41 are open to participants now.
This study's planned enrollment of 400 is above the median of 180 across 95 interventional studies indexed under Neonatal Sepsis.
Browse Neonatal Sepsis studies →Armed Forces Hospital, Pakistan is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The participants in this arm will receive a single dose of 2 g oral azithromycin along with standard care in the intrapartum period
Drug: oral azithromycin
participants in this arm will be given only standard labor care and no antibiotics
Other: no azithromycin
we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries
participants in this arm will be given only standard labor care and no oral azithromycin
maternal infections
Time frame: birth to 6 weeks post partum
neonatal infections
Time frame: birth to 6 weeks post partum
No study locations are listed for this record.
Plan to share: Yes — we will upload the data on the website on clinicaltrials.gov
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Armed Forces Hospital, Pakistan